Jan. 14 Recordati Industria Chimica e Farmaceutica S.p.A. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 11:15 AM
Jan. 14 Recordati : 14 January 2026 - J.P. Morgan Healthcare Conference Presentation PU
Jan. 12 Recordati Acquires 74,165 Own Ordinary Shares AN
Jan. 07 STRM.BIO, Inc. announces tranche update CI
Jan. 05 Recordati Buys Back 52,000 Own Shares for Over EUR2 Million AN
Dec. 31 US FDA declines to approve Corcept's drug for rare hormonal disorder RE
Dec. 23 Recordati Acquires 13,050 Own Shares for Approximately EUR570,000 AN
Dec. 18 Mixed European Markets, Central Banks in the Spotlight AN
Dec. 17 Mixed European Markets Ahead of ECB Decision, Mib Turns Bullish AN
Dec. 17 Mixed results in Europe; Saipem leads the gains AN
Dec. 17 Mib opens higher; strength in banking stocks AN
Dec. 16 Recordati launches new buyback program of up to EUR55 million AN
Dec. 10 Felice La Corte buys 4,000 Recordati shares AN
Dec. 08 Mib down; MPS at the top of the list AN
Dec. 08 Recordati CEO Acquires 2,000 Ordinary Shares AN
Nov. 23 Ex-dividend day for interim dividend FA
Nov. 17 Futures show stability; macro data expected AN
Nov. 14 Mib Drops Below 44,000; Azimut Bucks the Trend AN
Nov. 14 Recordati : First nine months 2025 PU
Nov. 13 Mib at 45,000 points; Buzzi and Azimut down sharply AN
Nov. 13 European Markets Set to Open Higher After End of U.S. Shutdown AN
Nov. 12 European Markets Climb, Mib Leads with Mediobanca AN
Nov. 12 Recordati Industria Chimica e Farmaceutica S.p.A., Nine Months 2025 Earnings Call, Nov 12, 2025
Nov. 12 Mediobanca Leads Gains; Strong Performance for De' Longhi on the Mid-Cap AN
Nov. 12 European stocks rally; Fed and US optimism as markets reopen AN
No results for this search